Elena Prokupets, Director at C4 Therapeutics, Inc. (CCCC), sold 131,330 shares at $48.71 ($6.4M) on 2021-09-15, disclosed to the SEC on 2021-09-16.
Open-market sale of $6.4M CCCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 492 | $25K | 0.4% |
| 2 | $50.03 | 492 | $25K | 0.4% |
| 3 | $48.71 | 30,000 | $1.5M | 22.8% |
| 4 | $48.97 | 24,193 | $1.2M | 18.5% |
| 5 | $48.97 | 24,193 | $1.2M | 18.5% |
| 6 | $48.62 | 25,807 |
| $1.3M |
| 19.6% |
| 7 | $48.62 | 25,807 | $1.3M | 19.6% |
| 8 | $50.01 | 346 | $17K | 0.3% |
| Total | $48.78 avg | 131,330 | $6.4M | 100% |
| Filing → |
| CCCC | SELL | 2021-09-21 | $2.1M | — | Filing → |
| CCCC | SELL | 2021-09-14 | $527K | — | Filing → |
| CCCC | SELL | 2021-08-05 | $1.3M | — | Filing → |